These are exciting times in biologics. Since 1995, applications for biotech patents have increased 25% year-on-year and biologics currently make up more than 50% of drugs in development. And, with many big deals already on the ledger this year…
The quality of your bioanalytical process will determine the quality of your study and with the right solution, the process can flow seamlessly.
Strict regulations, tight budgets and changing compliance needs are forcing pharma companies to employ new technology. Many are turning to cloud technology because it provides true scalability and helps free up time and resources that can be refocused on…